Submission Details

Molecule(s):
COc1ccc2c(c1)C1CC2C(c2ccccc2)N1C(=O)CCl

MAK-UNK-bae89c02-1

COc1ccc2c(c1)C1CC2C(c2ccccc2)N1C(=O)CCl

N#Cc1ccccc1CN(C1CCC(O)CC1)C1CC2CC1CN2C(=O)CCl

MAK-UNK-bae89c02-2

N#Cc1ccccc1CN(C1CCC(O)CC1)C1CC2CC1CN2C(=O)CCl

NS(=O)(=O)c1ccc2cccc(CN3CC4CC3CN4C(=O)CCl)c2c1

MAK-UNK-bae89c02-3

NS(=O)(=O)c1ccc2cccc(CN3CC4CC3CN4C(=O)CCl)c2c1

piperazine-chloroacetamide Check Availability on Manifold View
NS(=O)(=O)CCc1ccccc1CN1CC2CC1CN2C(=O)CCl

MAK-UNK-bae89c02-4

NS(=O)(=O)CCc1ccccc1CN1CC2CC1CN2C(=O)CCl

piperazine-chloroacetamide Check Availability on Manifold View

Design Rationale:

ordered chloroacetamides modified by adding an extra C atom above a piperidine or piperazine ring (similar to x0770 transformed into x3077)

Inspired By:
Discussion: